OA

EBSCO Information Services Releases Serials Price Projection Report for 2023

Retrieved on: 
Thursday, September 29, 2022

IPSWICH, Mass., Sept. 29, 2022 /PRNewswire-PRWeb/ -- EBSCO Information Services (EBSCO) has published the 2023 Serials Price Projection Report. This year's report projects that the overall effective publisher price increases for academic and academic medical libraries are expected to be (before any currency impact) in the range of three to five percent for individual e-journal titles, two to three percent for e-journal packages and four to six percent for print titles.

Key Points: 
  • IPSWICH, Mass., Sept. 29, 2022 /PRNewswire-PRWeb/ -- EBSCO Information Services (EBSCO) has published the 2023 Serials Price Projection Report .
  • Published annually, EBSCO's Serials Price Projections is based on surveys of a wide range of publishers and reviews of historical serials pricing data to assist information professionals as they make budgeting decisions for the upcoming renewals season.
  • Although this report is based upon careful analysis, EBSCO recommends using caution when using these projections, as they rely on historical trends and current estimates.
  • To read the 2023 Serials Price Projection Report in its entirety and view the Five-Year Journal Price Increase History, visit: https://www.ebsco.com/sites/default/files/acquiadam-assets/EBSCO-Five-Ye...
    EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world.

Huawei Releases the Striding Towards the Intelligent World - Data Storage White Paper

Retrieved on: 
Friday, September 23, 2022

IT data applications will become more diversified, and increasing volumes of application data will be processed by the production systems, meaning the need for reliable, performant, cost-effective data storage is more important than ever.

Key Points: 
  • IT data applications will become more diversified, and increasing volumes of application data will be processed by the production systems, meaning the need for reliable, performant, cost-effective data storage is more important than ever.
  • For this reason, the Striding Towards the Intelligent World - Data Storage white paper presents Huawei's outlook for the storage evolution in enterprise data centers.
  • Covering 9 topics, it provides enterprise customers with recommendations on data infrastructure development to jointly foster the data storage industry.
  • Green data storage is a must for data centers to reach net-zero carbon emissions.

Huawei Releases the Striding Towards the Intelligent World - Data Storage White Paper

Retrieved on: 
Friday, September 23, 2022

IT data applications will become more diversified, and increasing volumes of application data will be processed by the production systems, meaning the need for reliable, performant, cost-effective data storage is more important than ever.

Key Points: 
  • IT data applications will become more diversified, and increasing volumes of application data will be processed by the production systems, meaning the need for reliable, performant, cost-effective data storage is more important than ever.
  • For this reason, the Striding Towards the Intelligent World - Data Storage white paper presents Huawei's outlook for the storage evolution in enterprise data centers.
  • Covering 9 topics, it provides enterprise customers with recommendations on data infrastructure development to jointly foster the data storage industry.
  • Enterprises can deploy storage products with high-density designs, system convergence, and efficient data reduction to further reduce data center energy consumption.

Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study

Retrieved on: 
Thursday, September 22, 2022

Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, presented results from the pivotal Calypso Study of the MISHA Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis.

Key Points: 
  • Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, presented results from the pivotal Calypso Study of the MISHA Knee System, an implantable shock absorber (ISA) for the treatment of knee osteoarthritis.
  • The Calypso Study demonstrated superiority of its primary endpoint and reported clinically significant reduction in pain scores and improvement in function scores for participants receiving the MISHA Knee System.
  • Over 90% of the patients receiving the MISHA Knee System experienced substantial, clinically meaningful pain relief and functional improvement.
  • In Dr. Diduchs data presentation of the Calypso Study, the MISHA Knee System met its primary endpoint and was found to be superior to high tibial osteotomy at two years.

SHAYNE PAX Explores Unconditional Love Starring in New Arthouse Drama Film 'PERIDOT' Releasing October 4, 2022 by Gravitas Ventures

Retrieved on: 
Thursday, September 22, 2022

LOS ANGELES, Sept. 22, 2022 /PRNewswire/ -- Unconditional love is explored through a unique friendship in the new arthouse drama feature film, Peridot.

Key Points: 
  • LOS ANGELES, Sept. 22, 2022 /PRNewswire/ -- Unconditional love is explored through a unique friendship in the new arthouse drama feature film, Peridot.
  • Helmed by filmmaker-actor Shayne Pax, the film releases TVOD on October 4th by Gravitas Ventures, an Anthem Sports & Entertainment company, after making its World Premiere at NoHo CINEFEST on September 29th.
  • When he forms the most unlikely friendship with Martha, an elderly woman and renowned author, the two become fiercely intertwined and find unconditional love in the process.
  • Up next, Pax will appear in Nick Stoller's Apple TV+ comedy series Platonic, starring Seth Rogen and Rose Byrne.

FlexAgain Launches Innovative New Joint Supplement To The US Market

Retrieved on: 
Wednesday, September 21, 2022

MIAMI, Sept. 21, 2022 /PRNewswire/ -- FlexAgain , established in the United Kingdom, is bringing their joint supplement formula to the US.

Key Points: 
  • MIAMI, Sept. 21, 2022 /PRNewswire/ -- FlexAgain , established in the United Kingdom, is bringing their joint supplement formula to the US.
  • The first batch of their joint supplement produced in the US sold out in weeks with FlexAgain now being on back order till November the 1st.
  • He continued, "Like most supplements, it's not a perfect solution, but it will definitely help more than anything else I've seen on the over-the-counter joint supplement market."
  • The supplement isn't designed to eradicate more severe cases of joint pain, but thousands of customers are now claiming that it has substantially reduced joint soreness and stiffness.

Moximed to Unveil Data from Pivotal Study of MISHA™ Knee System for First Time at Orthopaedic Summit (OSET) 2022

Retrieved on: 
Thursday, September 15, 2022

Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, will present key data from the pivotal study of the MISHA Knee System at the 12th Orthopaedic Summit (OSET).

Key Points: 
  • Voshell Professor of Sports Medicine, Department of Sports Medicine, University of Virginia, will present key data from the pivotal study of the MISHA Knee System at the 12th Orthopaedic Summit (OSET).
  • The presentations will be part of a CME-accredited surgical congress and will be featured in a session on Knee Cartilage and Biologics.
  • Specifically, the faculty were asked to consider treatment options for a 43-year-old with moderate, but chronically painful, knee OA who wishes to remain physically active.
  • The companys technology, the MISHA Knee System, is the first implantable shock absorber for the treatment of medial compartment knee osteoarthritis (OA).

CCC Launches OA Agreement Intelligence

Retrieved on: 
Tuesday, September 13, 2022

CCC , a leading provider of Open Access (OA) workflow solutions, has launched OA Agreement Intelligence , the only agreement modeling solution that enables publishers to prepare, build, and analyze their OA data so that they can create and communicate sustainable and transparent agreements with their partners.

Key Points: 
  • CCC , a leading provider of Open Access (OA) workflow solutions, has launched OA Agreement Intelligence , the only agreement modeling solution that enables publishers to prepare, build, and analyze their OA data so that they can create and communicate sustainable and transparent agreements with their partners.
  • OA Agreement Intelligence transforms the agreement modeling process by supporting better visibility and communications to facilitate collaboration with our partners.
  • OA Agreement Intelligence helps publishers achieve scalability, sustainability, and transparency goals for institutional agreements.
  • OA Agreement Intelligence is part of CCCs growing OA service suite, including RightsLink for Scientific Communications , the solution that makes it easy for scholarly publishers of all sizes to manage OA institutional agreements and collect publication charges.

Cytonics Corporation to Webcast Live at VirtualInvestorConferences.com on September 15th at 12pm EST

Retrieved on: 
Thursday, September 8, 2022

This will be a live, interactive online event where investors are invited to ask the company questions in real-time.

Key Points: 
  • This will be a live, interactive online event where investors are invited to ask the company questions in real-time.
  • If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
  • It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.
  • Cytonics is currently developing a synthetic, genetically modified super A2M protein that is 2-4x more potent than the naturally occurring A2M molecule.

Apos®, a Non-Invasive Knee Treatment, Proven to Delay Surgery According to a Real-World Study

Retrieved on: 
Wednesday, September 7, 2022

Secondary outcomes of the study, at one year, showed a significant reduction in pain and disability, an increase in quality of life, and improved gait patterns.

Key Points: 
  • Secondary outcomes of the study, at one year, showed a significant reduction in pain and disability, an increase in quality of life, and improved gait patterns.
  • "As the lead researcher on this study, we are impressed at how the clinical results of our study reinforce Apos' place in the knee osteoarthritis care pathway by offering patients a non-invasive treatment option."
  • "These findings further validate Apos as a viable way to delay surgery for sufferers of knee osteoarthritis, and a key solution to be added to a patient care plan."
  • Avoidance of Total Knee Replacement in a Population Health Setting: Introducing a Noninvasive Biomechanical Intervention for Patients with Knee Osteoarthritis.